112 related articles for article (PubMed ID: 22036753)
1. Prenatal diagnosis of β-thalassemia: nuchal translucency in affected fetuses.
Di Fraja D; Sarno L; Migliucci A; Acampora E; Napolitano R; Maruotti GM; Martinelli P
Minerva Ginecol; 2011 Dec; 63(6):491-4. PubMed ID: 22036753
[TBL] [Abstract][Full Text] [Related]
2. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
3. Fetal nuchal translucency and prenatal diagnosis of beta-thalassaemia.
Monni G; Ibba RM; Zoppi MA; Putzolu M; Floris M; Cao A
Prenat Diagn; 1999 Aug; 19(8):758-60. PubMed ID: 10451523
[TBL] [Abstract][Full Text] [Related]
4. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
5. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
7. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
[TBL] [Abstract][Full Text] [Related]
8. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
9. [Application of chromosome microarray analysis for fetuses with increased nuchal translucency and a normal karyotype].
Yang X; Fu F; Li R; Zhang Y; Wan J; Yang X; Han J; Pan M; Zhen L; Liao C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):370-4. PubMed ID: 26037353
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
[TBL] [Abstract][Full Text] [Related]
11. Enlarged nuchal translucency in chromosomally normal fetuses: strong association with orofacial clefts.
Timmerman E; Pajkrt E; Maas SM; Bilardo CM
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):427-32. PubMed ID: 20499406
[TBL] [Abstract][Full Text] [Related]
12. Use of fetal nuchal translucency in the first trimester to predict single-gene disorders.
Arigita M; Borrell A; Mula R; Sanchez A; Milà M; Gratacos E
Prenat Diagn; 2011 Dec; 31(12):1164-8. PubMed ID: 22025256
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities.
Alexioy E; Alexioy E; Trakakis E; Kassanos D; Farmakidis G; Kondylios A; Laggas D; Salamalekis E; Florentin L; Kanavakis E; Basios G; Trompoukis P; Georgiadoy L; Panagiotopoulos T
J Matern Fetal Neonatal Med; 2009 Oct; 22(10):857-62. PubMed ID: 19521928
[TBL] [Abstract][Full Text] [Related]
14. Nuchal translucency thickness in the prediction of unbalanced translocations.
Arigita M; Grande M; Mula R; Borobio V; Sanchez A; Soler A; Borrell A
Prenat Diagn; 2014 Oct; 34(10):982-5. PubMed ID: 24863889
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
Müller MA; Clur SA; Timmerman E; Bilardo CM
Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
[TBL] [Abstract][Full Text] [Related]
16. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis.
Sotiriadis A; Papatheodorou S; Eleftheriades M; Makrydimas G
Ultrasound Obstet Gynecol; 2013 Oct; 42(4):383-9. PubMed ID: 23606595
[TBL] [Abstract][Full Text] [Related]
17. Fetal red blood cell hematology at mid-pregnancy among fetuses at risk of homozygous β-thalassemia disease.
Srisupundit K; Wanapirak C; Sirichotiyakul S; Tongprasert F; Luewan S; Traisrisilp K; Tongsong T
J Pediatr Hematol Oncol; 2013 Nov; 35(8):628-30. PubMed ID: 23887026
[TBL] [Abstract][Full Text] [Related]
18. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
19. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fetal nuchal translucency in 98 pregnancies at risk for severe spinal muscular atrophy: possible relevance of the SMN2 copy number.
Parra J; Alias L; Also-Rallo E; Martínez-Hernández R; Senosiain R; Medina C; Alejos O; Rams N; Amenedo M; Ormo F; Jesús Barceló M; Calaf J; Baiget M; Bernal S; Tizzano EF
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1246-9. PubMed ID: 22082206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
